life sciences bpo market - global industry analysis, size, share, growth, trends and forecast, 2013...
Post on 18-Jan-2015
Embed Size (px)
DESCRIPTIONTransparency Market Research is Published new Market Report "Life Sciences BPO Market [Contract Research Organizations (Drug Discovery, Pre-Clinical, Clinical Trials, Medical Writing, Pharmacovigilance, Risk-Based Monitoring, Clinical Data Management, Biostatistics) and Contract Manufacturing Organizations]- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global Life Sciences BPO market was valued at USD 152.5 billion in 2012 and is estimated to reach a market value worth USD 596.0 billion in 2019, growing at a CAGR of 21.5% from 2013 to 2019. Browse Life Sciences BPO Market Report with Full TOC: http://www.transparencymarketresearch.com/life-sciences-bpo-market.html
- 1. Transparency Market Research (TMR) provides a range of marketing and business research solutions designed for your specific needs. From off-the-shelf syndicated business & market research to made-to-order custom research, we serve our clients to fulfill their immediate as well as ongoing research requirements. Contact Us : State Tower,90 State Street,Suite 700,Albany NY 12207,United States Tel: +1-518-618-1030 Email: email@example.com
2. Single User License: US $ 4795 Multi User License: US $ 7795 Corporate User License: US $ 10795 206 Pages Repor t Published Date : Feb 2014 Buy Now Request Sample Life Sciences BPO Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 3. Transparency Market Research is Published new Market Report " Life Sciences BPO Market [Contract Research Organizations (Drug Discovery, Pre-Clinical, Clinical Trials, Medical Writing, Pharmacovigilance, Risk-Based Monitoring, Clinical Data Management, Biostatistics) and Contract Manufacturing Organizations]- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global Life Sciences BPO market was valued at USD 152.5 billion in 2012 and is estimated to reach a market value worth USD 596.0 billion in 2019, growing at a CAGR of 21.5% from 2013 to 2019. Rising cost, growing complexities of conducting clinical trials and increased pressure from regulatory agencies to adopt various techniques to minimize the costs involved for successful introduction of a drug in the market has compelled pharmaceutical players to adopt new outsourcing models. All these factors have helped fuel market growth of the Life Sciences BPO industry in the past decade. In addition, rise in the number of patent expirations and failure of drugs during the clinical trials process has triggered the overall growth of pharmaceutical outsourcing industry. Moreover, outsourcing aids the biotechand pharmaceutical industry to focus on their core strategies and utilize their internal resources for more critical in-house projects. The Contract Manufacturing Organizations (CMOs) outsourcing services accounts for the largest segment of the overall Life Sciences BPO market. Growing healthcare costs has led to a rise in the demand for generic drugs and this has consequently led to growth in demand for active pharmaceutical outsourcing services. Moreover, CMOs conduct internal R&D to come up with novel technologies to further support their clients. The API manufacturing market accounts to be largest segment of the total CMO market. This growth has been attributed to increase in outsourcing activities for pharmaceutical manufacturing outsourcing, owing to increasing regulatory compliance such cGMP and other approvals. Moreover, manufacturers do not have all the technologies and expertise available in-house required for manufacturing different APIs and hence, outsourcing serves as a more cost effective solution for pharmaceutical companies. Also, the growing importance of biological drugs calls for distinctive manufacturing technology. The Contract Research Organizations (CROs) outsourcing services market has also witnessed significant growth in the past decade. This growth has been attributed to the rising costs involved in conducting various phases of clinical trials ranging from drug discovery up to post marketing approvals. Pharmaceutical companies are now opting to PR : Life Sciences BPO Market is Expected to Reach USD 596.0 Billion Globally in 2019: Transparency Market Research 4. outsource their clinical trial activities to vendorscapable of providing bundled services such as regulatory services, clinical data management, medical writing, site management, pharmacovigilance, risk based monitoring, biostatics, protocol development and others. The drug discovery services segment accounted for the largest market share in 2012.Since a large number of molecules fail during the drug discovery process, through outsourcing the pharmaceutical companies are mitigating their financial risks and avoiding sunken costs through partnership with CROs. However, clinical data management outsourcing services market is expected to foresee the highest growth rate of 17.3% from 2013 to 2019. This high growth has been attributed to the growing adoption of advanced IT services such cloud applications and enhanced software services provided by Information Technology Outsourcing (ITO). Data security and Intellectual Property Rights (IPR)still persist to be major hindrance for growth of this industry. Browse Life Sciences BPO Market Report with Full TOC at http://www.transparencymarketresearch.com/life-sciences-bpo-market.html Geographically, North America accounted for the largest share of the global pharmaceutical outsourcing services market in 2012 and was valued at USD 28.4 billion in 2012 followed by Asia-Pacific. The Asian-Pacific region is expected to represent the highest growth rate of 21.2% during the forecast period owing to availability of trained resources, low cost labor, favorable regulatory policies and huge patient pool suffering from varies chronic diseases. Moreover, the companies from this region are now meeting the required manufacturing and quality standards of the USFDA and EMEA to further boost market growth. The major players in this market include Catalent Pharma Solutions, Lonza Group, Parexel International, PRA International, Piramal Healthcare, Charles River Laboratories, PPD (Pharmaceutical Product Development), Cognizant, Accenture, IBM, Quintiles, Covance and others. The global life sciences BPO market is segmented as follows: Global Life Sciences BPO Market, by Segments Pharmaceutical Outsourcing Market Contract Manufacturing Organizations (CMOs) Active Pharmaceutical Ingredients (APIs) Manufacturing Finished Dosage Formulation (FDF) Development and Manufacturing Packaging Contract Research Organizations (CROs) Drug Discovery 5. Pre-Clinical Studies Clinical Studies Medical Writing Clinical Data Management (CDM) Bio-Statistics Risk Based Monitoring Site Management Pharmacovigilance Regulatory Services Protocol Development Others Contract Sales Organizations (CSOs) Global Life Sciences BPO Market, by Geography North America Europe Germany France U.K. Italy Spain Switzerland ROE Asia-Pacific Rest of the World (RoW) 6. Related & Recently Published Reports by Transparency Market Research Ophthalmic Drugs Market: http://www.transparencymarketresearch.com/ophthalmic-drugs- market.html Contact Lens Market: http://www.transparencymarketresearch.com/contact-lens-market.html Molecular Diagnostics Market: http://www.transparencymarketresearch.com/molecular-diagnostics- industry.html Blood Flow Measurement Devices: http://www.transparencymarketresearch.com/blood-flow-measurement- devices.html Building and Construction Plastics Market: http://www.transparencymarketresearch.com/building-construction- plastics-market.html Organ Preservation Solutions Market: http://www.transparencymarketresearch.com/organ-preservation- solutions.html Table of Content Chapter 1 Introduction 1.1 Report Description 1.2 Research Methodology 1.3 Market Segmentation Chapter 2 Executive Summary 2.1 Market Snapshot: Global Life Sciences BPO Market (2012 & 2019) 7. 2.2 Global Pharmaceutical Outsourcing Market, by Service Type, 2012 (USD Billion) 2.3 Global CMO (Contract Manufacturing Organizations) Market, by Service Type, 2012 (USD Billion) 2.4 Global CRO (Contract Research Organizations) Market, by Service Type, 2012 (USD Billion) Chapter 3 Global Life Sciences BPO Market Dynamics 3.1 Introduction 3.1.1 Drivers 18.104.22.168 Rising cost of R&D and decline in productivity 22.214.171.124 Patent expirations to boost CMO industry growth 126.96.36.199 Globalization of drug development with shift of manufacturing activities from high cost to low cost regions 188.8.131.52 Restructuring of pharmaceutical production 3.1.2 Restraints 184.108.40.206 Data safety concerns 220.127.116.11 Stringent and varied regulatory approval processes in different countries 18.104.22.168 Unforeseen Costs has marred the growth of CRO industry 3.1.3 Opportunities 22.214.171.124 Biologics 126.96.36.199 Emerging markets 3.2 Value Chain Analysis 3.2.1 People Skills and Challenges for Life Sciences BPO Services: 3.2.2 Pharmaceutical Outsourcing 3.2.3 Contract Research Outsourcing Market: 3.2.4 Value Chain Analysis: Contract Research Outsourcing Market 3.2.5 Contract Research Outsourcing Services (%), 2012 8. 188.8.131.52 Contract Research Outsourcing Services (%), 2012 3.2.6 Pharmacovigilance 184.108.40.206 Value Chain Analysis: Pharmacovigilance 3.2.7 Biostatistics 220.127.116.11 Value Chain Analysis: Biostatistics 3.2.8 Risk-based Monitoring 18.104.22.168 Value Chain Analysis: Risk based Monitoring 3.2.9 Study Design and Protocol Development 22.214.171.124 Value Chain Analysis: Study Design and Protocol Development 3.2.10 Medical Writing 126.96.36.199 Value Chain Analysis: Medical Writing 3.2.11 Clinical Data Management 188.8.131.52 Value Chain Analysis: Clinical Data Management 3.2.12 Site Management 184.108.40.206 Value Chain Analysis: Site Management 3.2.13 Regulatory Services 220.127.116.11 Value Chain Analysis: Regulatory Services 3.3 Porters Five Force Analysis: Global Life sciences BPO Market 3.3.1 Bargaining Power of Suppliers 3.3.2 Bargaining Power of Buyers 3.3.3 Threat of New Entrants 3.3.4 Threat of Substitutes 3.3.5 Competitive Rivalry 3.4 Market Attractiveness Analysis of the Global Life Sciences BPO Market, by Geography 3.4.1 Market Attractiveness Analysis: Global Life Sciences BPO Market, 2012, by Geography 9. 3.5 Market Attractiveness Analysis of the Global Life Sciences BPO Market, by Europe 3.5.1 Market Attractiveness Analysis: Europe Life Sciences BPO Market, 2012, by Geography Chapter 4 Global Life Sciences BPO Market, by Segments 4.1 Overview 4.2 Pharmaceutical Outsourcing 4.2.1 Contract Manufacturing Outsourcing 18.104.22.168 Active Pharmaceutical Ing